86
K.E. Slessor et al. / Bioorganic Chemistry 38 (2010) 81–86
tute the Rossmann Fold [GXX(X)GX(X)G and YXXXK] were found in
the protein sequence of (1R)-6b-hydroxycineole dehydrogenase.
The Rossmann Fold allows for the binding of NADH/NAD+ during
the reduction/oxidation of the substrate [17,18]. The first
(GAAQGMG (14-20) is very close to the N-terminus to which the
His-tag was attached. His-tags have previously been demonstrated
to affect enzyme activity in some cases [19]. For example, glucosa-
mine-6-phosphate synthase from Candida albicans was expressed
in E. coli with a His-tag at the N-terminus. It was found to lose
activity completely. Once the His-tag was placed at the C-terminus
rather than the N-terminus the enzyme regained activity [19]. We
hypothesised that divalent nickel ions could coordinate to the His-
tag and remove it from the NAD(H) binding site. It was also possi-
ble that the enzyme may require a metal-ion for catalysis. Another
dehydrogenase, 5-exo-hydroxycamphor dehydrogenase from P.
putida, that catalyses a similar reaction, converting 5-exo-hydroxy-
camphor to 2,5-diketocamphane is believed to have two firmly
bound zinc atoms per subunit [10]. In an attempt to improve the
rates of turnover of (1R)-6b-hydroxycineole dehydrogenase, vari-
ous divalent metal ions were added to the reaction. Interestingly,
only nickel and cobalt were observed to increase the activity
(10–15-fold). This, together with the observation that nickel did
not improve the activity of (1R)-6b-hydroxycineole dehydrogenase
without the His-tag (vide infra), suggested that the His-tag had
been coordinated by the nickel or cobalt, exposing the NAD(H)
binding site. In addition, (1R)-6b-hydroxycineole dehydrogenase
does not have any significant homology with 5-exo-hydroxycam-
phor dehydrogenase, or the zinc-containing dehydrogenases in
general.
The second approach to improving the activity was to remove
the His-tag enzymatically using AcTEV™ protease. This approach
also resulted in an enzyme with increased activity (Table 2;
approximately 2-fold). The additional overnight incubation and
purification of the enzyme is thought to be responsible for the only
moderate increase in activity compared to that observed with the
His-tagged (1R)-6b-hydroxycineole dehydrogenase in the presence
of nickel as we had previously observed loss of activity in the en-
zyme upon storage at room temperature. Interestingly, the Km
(NAD+) for the cleaved-dehydrogenase was not as low as that for
the nickel-coordinated His-tagged-dehydrogenase (Table 2). This
perhaps suggests that the eight amino acids left at the N-terminus
following cleavage are still large enough to interfere with the opti-
mal binding of NAD+ to the enzyme.
ered the activity of the enzyme. This activity could be recovered
via the addition of Ni2+ ions, postulated to coordinate to the His-
tag and thus allow NAD(H) to access its binding site. (1R)-6b-
hydroxycineole dehydrogenase is stereo- and enantioselective,
only accepting (1R)-6b-hydroxycineole (2a). Importantly, this is
the same enantiomer produced by P450cin during the oxidation
of 1,8-cineole linking these two activities in cineole biodegradation
[8].
Acknowledgments
The authors would like to thank Yen-Yin Pan for early work on
the cleavage of the His-tag. This work was supported in part by
ARC Grant DP0881116.
References
[1] J. Gershenzon, N. Dudareva, Nat. Chem. Biol. 3 (2007) 408–414.
[2] C.J.D. Mau, R. Croteau, Phytochem. Rev. 5 (2006) 373–383.
[3] R.M. Carman, M.T. Fletcher, Aust. J. Chem. 36 (1983) 1483–1493.
[4] I.C. MacRae, V. Alberts, R.M. Carman, I.M. Shaw, Aust. J. Chem. 32 (1979) 917–
922.
[5] T.M. Flynn, I.A. Southwell, Aust. J. Chem. 32 (1979) 2093–2095.
[6] P.W. Trudgill, Biodegradation 1 (1990) 93–105.
[7] D.R. Williams, P.W. Trudgill, D.G. Taylor, J. Gen. Microbiol. 135 (1989) 1957–
1967.
[8] D.B. Hawkes, G.W. Adams, A.L. Burlingame, P.R. Ortiz de Montellano, J.J. De
Voss, J. Biol. Chem. 277 (2002) 27725–27732.
[9] H. Koga, H. Aramaki, E. Yamaguchi, K. Takeuchi, T. Horiuchi, I.C. Gunsalus, J.
Bacteriol. 166 (1986) 1089–1095.
[10] H. Aramaki, H. Koga, Y. Sagara, M. Hosoi, T. Horiuchi, BBA-Gene Struct. Expr.
1174 (1993) 91–94.
[11] J.A. Peterson, J.Y. Lu, J. Geisselsoder, S. Graham-Lorence, C. Carmona, F. Witney,
M.C. Lorence, J. Biol. Chem. 267 (1992) 14193–14203.
[12] R.M. Carman, M.T. Fletcher, Aust. J. Chem. 37 (1984) 1117–1122.
[13] J.K. Yang, M.S. Park, G.S. Waldo, S.W. Suh, Proc. Natl. Acad. Sci. USA 100 (2003)
455–460.
[14] T.D. Parks, K.K. Leuther, E.D. Howard, S.A. Johnston, W.G. Dougherty, Anal.
Biochem. 216 (1994) 413–417.
[15] F. Sweet, B.R. Samant, Biochemistry 19 (1980) 978–986.
[16] C.A.F. Edwards, J.C. Orr, Biochemistry 17 (1978) 4370–4376.
[17] S.T. Rao, M.G. Rossmann, J. Mol. Biol. 76 (1973) 241–250.
[18] G. Kleiger, D. Eisenberg, J. Mol. Biol. 323 (2002) 69–76.
[19] J. Olchowy, K. Kur, P. Sachadyn, S. Milewski, Protein Expres. Purif. 46 (2006)
309–315.
[20] T.P. Stinear, T. Seemann, P.F. Harrison, G.A. Jenkin, J.K. Davies, P.D.R. Johnson, Z.
Abdellah, C. Arrowsmith, T. Chillingworth, C. Churcher, et al., Genome Res. 18
(2008) 729–741.
[21] J. Ishikawa, A. Yamashita, Y. Mikami, Y. Hoshino, H. Kurita, K. Hotta, T. Shiba,
M. Hattori, Proc. Natl. Acad. Sci. USA 101 (2004) 14925–14930.
[22] S.D. Bentley, K.F. Chater, A.M. Cerdeno-Tarraga, G.L. Challis, N.R. Thomson, K.D.
James, D.E. Harris, M.A. Quail, H. Kieser, D. Harper, et al., Nature 417 (2002)
141–147.
[23] N.H. Schlieben, K. Niefind, J. Muller, B. Riebel, W. Hummel, D. Schomburg, J.
Mol. Biol. 349 (2005) 801–813.
[24] R.G. Silva, L.P.S. de Carvalho, J.S. Blanchard, D.S. Santos, L.A. Basso,
Biochemistry 45 (2006) 13064–13073.
[25] D.B. Hawkes, K.E. Slessor, P.V. Bernhardt, J.J. De Voss, submitted for
publication.
In summary, we have demonstrated that the gene product of
cinD from C. braakii exhibits (1R)-6b-hydroxycineole dehydroge-
nase activity and also catalyses the reverse reaction, reducing
(1R)-6-ketocineole (3a) to (1R)-6b-hydroxycineole (2a). During
this study it was observed that the N-terminal His-tag used to as-
sist purification interfered with the NAD(H) binding site and low-